Sign In
Buy ONTX
$1.00
+0 (+0%)
At Close: Jul 01, 2024
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023
04:05pm, Thursday, 04'th May 2023
Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023 Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023
3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029%
11:28am, Tuesday, 25'th Apr 2023
Analysts say these are penny stocks to buy but do you agree? The post 3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% appeared first on Penny Stocks to Buy, Picks, News and Informati
5 Hot Penny Stocks To Watch With The Stock Market Down This Week
01:15pm, Monday, 24'th Apr 2023
Hot penny stocks to watch this week. This is a significant week for earnings, and mega-cap tech names will headline what's sure to be a volatile week. Next week, the action continues with the upcoming
Penny Stocks To Buy Now? 5 With Big News Today
10:22am, Friday, 21'st Apr 2023
Penny stocks news sparks momentum in the stock market today. The post Penny Stocks To Buy Now?
Onconova Therapeutics, Inc. (ONTX) Q4 2022 Earnings Call Transcript
09:56pm, Thursday, 16'th Mar 2023
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors Steven Fruchtman - CEO, President & Director
Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
04:05pm, Thursday, 09'th Mar 2023
Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023 Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
08:00am, Wednesday, 07'th Dec 2022
NEWTOWN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients
Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference
08:00am, Monday, 28'th Nov 2022
NEWTOWN, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients
Onconova Therapeutics, Inc. (ONTX) Q3 2022 Earnings Call Transcript
08:54pm, Monday, 14'th Nov 2022
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Bruce Mackle - Investor Relations, LifeSci Advisors Dr. Steve Fruchtman - P
Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates
06:48pm, Monday, 14'th Nov 2022
Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022
04:05pm, Monday, 07'th Nov 2022
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, November 14, 2022 Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, November 14, 2022
Onconova Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
08:00am, Thursday, 22'nd Sep 2022
NEWTOWN, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel pr
Onconova Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08:00am, Thursday, 01'st Sep 2022
NEWTOWN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel pr
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2022 Results - Earnings Call Transcript
11:14pm, Thursday, 11'th Aug 2022
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Bruce Mackle - Investor Relations, LifeSci Advisors Steve Fruchtman - Presid
Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates
06:49pm, Thursday, 11'th Aug 2022
Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of 5% and 5%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
